| OMB APPROVAL | |
|
OMB Number 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response 2.50 |
|
| UNITED STATES | |
|
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
SEC FILE NUMBER 001-14053 |
| FORM 12b-25 | |
|
NOTIFICATION OF LATE FILING |
CUSIP NUMBER 59935P209 |
(Check One):☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR
For Period Ended: December 31, 2024
☐ Transition Report on Form 10-K
☐ Transition Report on Form 20-F
☐ Transition Report on Form 11-K
☐ Transition Report on Form 10-Q
For the Transition Period Ended: ____________________________________________
|
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I – REGISTRANT INFORMATION
Milestone Scientific Inc.
Full Name of Registrant
425 Eagle Rock Avenue, Suite 403
Address of Principal Executive Office (Street and Number)
Roseland, NJ 07068
City, State and Zip Code
PART II – RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense |
|
|
x |
(b)The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|
(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III – NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
The verification and review of the information required to be presented in the Form 10-K has required additional time, rendering timely filing of the Form 10-K on the statutory due date impracticable without undue hardship and expense to the Registrant.
PART IV – OTHER INFORMATION
|
(1) |
Name and telephone number of person to contact in regard to this notification |
|
Neal Goldman |
(973) |
535-2717 |
|
(Name) |
(Area Code) |
(Telephone Number) |
|
(2) |
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No |
|
(3) |
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No |
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
Milestone Scientific Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: March 27, 2025 |
By: |
/s/ Neal Goldman |
|
Neal Goldman Acting Chief Executive Officer |